GSK inks testosterone replacement therapy co-promotion deal
Specialty pharmaceutical company Auxilium Pharmaceuticals (NASDAQ:AUXL) has inked a deal with GlaxoSmithKline (NYSE:GSK) to co-promote its testosterone replacement therapy gel Testim in a bid to grab a bigger slice of the primary care physician market, which accounts for 70 percent of TRT gel prescriptions, according to a conference call detailing the deal. The deal, scheduled […]